Class II · Moderate risk
Cefixime for Oral Suspension USP
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
National Drug Code
Is NDC 68180-0405-01 recalled?
Cefixime · 50 mL in 1 BOTTLE (68180-405-01)
Yes — this exact package was recalled
4 FDA recalls name the code 68180-0405-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Cefixime
- Strength
- CEFIXIME 100 mg/5mL
- Form
- Powder, for Suspension · Oral
- Labeler
- Lupin Pharmaceuticals, Inc.
- Type
- Human Prescription Drug
- Product code
- 68180-0405
Recalls naming this package
Class II · Moderate risk
Cefixime for Oral Suspension 100mg/5mL
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Cefixime for Oral Suspension USP 100 mg/5mL
Subpotent Drug
Class II · Moderate risk
Cefixime for Oral Suspension USP
Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 68180-0723 Cefdinir 7
- 68180-0519 Lisinopril and Hydrochlorothiazide 4
- 68180-0422 Moxifloxacin 3
- 68180-0435 See recall 3
- 68180-0633 See recall 3
- 68180-0659 rifampin 3
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.